
Overview
Dr. Sofia Merajver received a doctoral degree in physics from the University of Maryland and a medical degree from the University of Michigan. She completed a residency in internal medicine and a fellowship in oncology at the University of Michigan before joining the faculty in 1994. Dr. Merajver, an expert in breast cancer genetics, is the medical director of the Breast and Ovarian Cancer Risk Evaluation Program at the U-M Rogel Cancer Center. Her research interests include the molecular genetics of breast cancer, gene function and cancer risk assessment. She enjoys literature, music and outdoor activities with her family.
Dr. Merajver is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Triple-Negative Breast Cancer, and Angiosarcoma.
Dr. Merajver is board certified in Medical Oncology. She is actively involved in clinical research, co-authoring 144 peer reviewed articles. Dr. Merajver is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
Locations
1500 E Medical Center Dr, Floor 1, Ann Arbor, MI 48109
Additional Areas of Focus
Dr. Merajver has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Rogel Cancer Center
Rashmi Chugh is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Chugh is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Desmoid Tumor, and Ewing Sarcoma. Dr. Chugh is currently accepting new patients.
Rogel Cancer Center
Scott Schuetze is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Schuetze is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Liposarcoma, Adult Soft Tissue Sarcoma, Angiosarcoma, and Myxoid Liposarcoma. Dr. Schuetze is currently accepting new patients.
Rogel Cancer Center
Dr. Vaishampayan is the Director of the Phase I program at the Rogel Cancer Center, University of Michigan, Ann Arbor MI. Dr. Vaishampayan is a Professor of Internal Medicine and her research is primarily in translational drug development and early phase clinical trials in cancer with a focus on genitourinary malignancies. She has initiated, obtained funding for, and conducted and published many investigator initiated trials with embedded biomarkers and established multidisciplinary collaboration. She has served as site PI of the UO-1 Early Therapeutics Research Grant at Wayne State University. She was also the chair of the solid tumor division of oncology at WSU. She has completed formal leadership traning course and is Fellow of the Advisory Board (FAB). She is the appointed chair of the Advanced Renal committee of SWOG and a member of the Renal task force of the NCI. She is a board member of the Michigan Society of Hematology/Oncology (MSHO) and organizes annual board review course. Additionally, she has served as track leader for the ASCO education committee GU non prostate (Renal and bladder cancer) track. Dr. Vaishampayan attended Wayne State University for her residency and fellowship completion and attended medical school at Byramjee Jeejeebhoy in Pune, India and completed a higher secondary certificate in the field of science at Fergusson College in Pune, India.In her free time, Dr. Vaishampayan enjoys reading, dance, music and travel. Travel, reading (mysteries preferred), follows football. Dr. Vaishampayan is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Urothelial Cancer, Prostate Cancer, Nephrectomy, and Orchiectomy. Dr. Vaishampayan is board certified in Medical Oncology. Dr. Vaishampayan is currently accepting new patients.
Frequently Asked Questions about Dr. Sofia D. Merajver
How do I make an appointment with Dr. Sofia D. Merajver?
You can book an appointment with Dr. Sofia D. Merajver by calling their office at 734-647-8902. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Sofia D. Merajver a top-rated expert for Inflammatory Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sofia D. Merajver is classified as an Elite expert for Inflammatory Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Sofia D. Merajver specialize in?
While Dr. Sofia D. Merajver is a Oncology, they have specific expertise in Inflammatory Breast Cancer, Breast Cancer, and Triple-Negative Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Sofia D. Merajver participate in research or clinical trials?
Yes. Dr. Sofia D. Merajver has published 144 articles and abstracts on conditions like Inflammatory Breast Cancer. You can view a list of Dr. Sofia D. Merajver's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Sofia D. Merajver accept my insurance?
Dr. Sofia D. Merajver accepts most major insurance plans, including Blue Cross Blue Shield and Humana. We recommend calling the office directly at 734-647-8902 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Merajver isElite. Learn about Breast Cancer.
- Inflammatory Breast CancerDr. Merajver isElite. Learn about Inflammatory Breast Cancer.
- Triple-Negative Breast CancerDr. Merajver isElite. Learn about Triple-Negative Breast Cancer.
- Distinguished
- AngiosarcomaDr. Merajver isDistinguished. Learn about Angiosarcoma.
- Advanced
- BRCA Positive Breast CancerDr. Merajver isAdvanced. Learn about BRCA Positive Breast Cancer.
- DICER1 SyndromeDr. Merajver isAdvanced. Learn about DICER1 Syndrome.
- HER2 Negative Breast CancerDr. Merajver isAdvanced. Learn about HER2 Negative Breast Cancer.
- Metastatic Brain TumorDr. Merajver isAdvanced. Learn about Metastatic Brain Tumor.
- Ovarian CancerDr. Merajver isAdvanced. Learn about Ovarian Cancer.
- Ovarian CarcinosarcomaDr. Merajver isAdvanced. Learn about Ovarian Carcinosarcoma.
- Paget Disease of the BreastDr. Merajver isAdvanced. Learn about Paget Disease of the Breast.
- Testicular Yolk Sac TumorDr. Merajver isAdvanced. Learn about Testicular Yolk Sac Tumor.
- Experienced
- Anal CancerDr. Merajver isExperienced. Learn about Anal Cancer.
- Bladder CancerDr. Merajver isExperienced. Learn about Bladder Cancer.
- Brain TumorDr. Merajver isExperienced. Learn about Brain Tumor.
- Breast Cancer in MenDr. Merajver isExperienced. Learn about Breast Cancer in Men.
- Desmoplastic Small Round Cell TumorDr. Merajver isExperienced. Learn about Desmoplastic Small Round Cell Tumor.
- Familial Colorectal CancerDr. Merajver isExperienced. Learn about Familial Colorectal Cancer.
- GliomaDr. Merajver isExperienced. Learn about Glioma.
- Gliomatosis CerebriDr. Merajver isExperienced. Learn about Gliomatosis Cerebri.
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- HER-2 Positive Breast CancerDr. Merajver isExperienced. Learn about HER-2 Positive Breast Cancer.
- Lung CancerDr. Merajver isExperienced. Learn about Lung Cancer.
- Malignant Mixed Mullerian TumorDr. Merajver isExperienced. Learn about Malignant Mixed Mullerian Tumor.
- Pancreatic CancerDr. Merajver isExperienced. Learn about Pancreatic Cancer.
- Prostate CancerDr. Merajver isExperienced. Learn about Prostate Cancer.
- Sertoli-Leydig Cell TumorDr. Merajver isExperienced. Learn about Sertoli-Leydig Cell Tumor.
- Virilizing Ovarian TumorDr. Merajver isExperienced. Learn about Virilizing Ovarian Tumor.


